Capecitabine / CAS 154361-50-9
Short Description:
Product name: Capecitabine
CAS: 154361-50-9
MF:C15H22FN3O6
MW: 359.35
STRUCTURE:
melting point：87℃
specification
| Item | Specification |
| Appearance | White or off-white crystalline powder |
| Moisture | ≤0.3% |
| Purity | ≥98.5% |
| Maximum single impurity | ≤0.5% |
Usage
Capecitabine is an antimetabolic fluoropyrimidine deoxyribonucleoside carbamate drug that can be converted into 5-FU in the body. It was developed by Roche and is marketed as Xeloda. It can inhibit cell division and interfere with RNA and protein synthesis. It is indicated for further treatment of advanced primary or metastatic breast cancer that is unresponsive to paclitaxel and chemotherapy regimens including anthracycline antibiotics. It is mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
Anti-cancer drugs are mainly used for non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
New oral fluoropyrimidine drugs
Packaging and Shipping
25KG/Drum or as customer requirements.
Belongs to common goods and can deliver by ocean and air
Keep and storage
Shelf life:24 month from date of manufacture in original unopened packaging stored in a cool dry place out of direct sunlight, water.
Ventilated warehouse, Low temperature drying, Separated from oxidants, acids.
